Kennedy Faces Scrutiny Over Pharmaceutical Ties
During a recent hearing, Director Robert F. Kennedy Jr. of Health and Human Services was put in the spotlight by Democrats on the House Energy Commerce Subcommittee. It seems the spotlight became intense when they probed him about the substantial campaign funds he allegedly received from the pharmaceutical industry.
New Jersey Congressman Frank Pallone, who is a Democrat, made a notable claim about Kennedy’s actions. He implied that Kennedy is promoting a pseudo-scientific agenda that could endanger public health. Pallone, during Tuesday’s session, expressed his strong concerns, stating, “Secretary, science is not on your side. I really think people will die as a result of your actions and Congressional Republican actions.”
One of Pallone’s main points of contention was the perceived lack of transparency in Kennedy’s decision-making processes. Yet, when Kennedy attempted to respond, Pallone interrupted, questioning whether Kennedy feared public input on controversial vaccine discussions. “What are you afraid of?” he pressed, implying that the public might disagree with Kennedy’s views, which diverge from mainstream scientific consensus.
Kennedy countered that there are indeed opportunities for public input via the ACIP Committee (Advisory Committee on Immunization Practices), contending it holds open meetings. However, Pallone highlighted an incident where Kennedy dismissed a Biden-appointed member from that committee, raising eyebrows about the integrity of its operations.
Kennedy recently made waves by terminating all 17 Biden administration appointees at ACIP, accusing the committee of having deep-rooted conflicts of interest and essentially functioning as a rubber stamp for pharmaceutical companies. Documents from OpenPaymentsData.cms.gov indicate that some former ACIP members have deep ties to the industry, which raises questions about their independence. For instance, Edwin Jose Asturias, a former member, reportedly received around $54,000 from companies he’s supposed to oversee.
Moreover, reports show that Asturias has been linked to over $3 million in research funding from large pharmaceutical firms such as Pfizer and GlaxoSmithKline. “I fired people who are at odds with the pharmaceutical industry,” Kennedy asserted to Pallone, pointing out that these connections lead to questions about credibility and accountability.
Even as tensions escalated, Pallone continued pressing Kennedy on restoring public trust in health agencies. At the hearing, Kennedy reminisced about their earlier encounters, suggesting that Pallone appeared to be championing vaccination causes in the past, yet has now accumulated significant financial support from the pharmaceutical sector.
According to OpenSecrets data, Pallone has received over $2.2 million from pharmaceutical and health product industries—a considerable sum since he took office in 1989. His contributions last year alone included over $15,000 from entities linked to Johnson & Johnson. Kennedy pointedly commented on Pallone’s shifted positions, suggesting that financial ties may have influenced his stance on vaccinations.
Another Democratic representative, Diana DeGette from Colorado, accused Kennedy of trying to undermine Pallone, insinuating that Pallone might not advocate for vaccine victims due to his financial relationships with pharmaceutical firms. This only added to the confrontational atmosphere, with Pallone suggesting that Kennedy should “defeat” his statements. After some back and forth, Pallone seemed to reconsider his earlier remarks while Kennedy made a wry comment about retracting his statements when appropriate.
